Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875624 · ClinicalTrials.gov registry record
Neurodevelopment of Hypoglycemic Neonates
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 126
- Enrollment target
NCT04875624 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 126 participants.
The verdict
NCT04875624 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The investigators propose to prospectively conduct a neurodevelopmental evaluation of SGA and late preterm neonates who underwent risk-based screening for hypoglycemia at newborn nursery during the first 24 hours of life based on AAP (American Academy of Pediatrics) hypoglycemia guidelines at 18 to 24 months of age. As per internal neonatal unit protocol (reflecting AAP guidelines), all neonates at risk of hypoglycemia (all preterm infants, term infants who are SGA or LGA and IDM) are routinely screened for hypoglycemia during the first 24 hours of life via bedside point of care glucose devices (see attached Weiler neonatal intensive care unit (NICU) hypoglycemia screening protocol). The investigators will compare neurodevelopmental outcomes of those who were and were not hypoglycemic in the newborn nursery based on electronic health record data.
Interventions
- DIAGNOSTIC_TEST Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2024-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04875624
The ClinicalTrials.gov registry entry for NCT04875624 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4) is the first listed.
NCT04875624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04875624 about?
NCT04875624 is a clinical study titled "Neurodevelopment of Hypoglycemic Neonates". The investigators propose to prospectively conduct a neurodevelopmental evaluation of SGA and late preterm neonates who underwent risk-based screening for hypoglycemia at newborn nursery during the first 24 hours of life based on AAP (American Academy of Pediatrics) hypoglycemia guidelines at 18 to ...
What is the current status of trial NCT04875624?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2021-07-14. Estimated completion is 2024-07-19.
What interventions are being tested in trial NCT04875624?
The interventions under investigation include: Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04875624?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.